Differential effect of systemic antibiotics and proton pump inhibitors on clinical outcomes from immunotherapy or placebo as sequential therapy in patients with locally advanced, unresectable non-small cell lung cancer (stage III) who have not progressed following chemoradiation therapy: A post-hoc analysis of the PACIFIC trial.

Alessio Cortellini

Open source

DOI
10.25934/pr00009018
Published
2024
Container
Not recorded
Publisher
Vivli
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.25934/pr00009018,
  title = {Differential effect of systemic antibiotics and proton pump inhibitors on clinical outcomes from immunotherapy or placebo as sequential therapy in patients with locally advanced, unresectable non-small cell lung cancer (stage III) who have not progressed following chemoradiation therapy: A post-hoc analysis of the PACIFIC trial.},
  author = {Alessio Cortellini},
  year = {2024},
  doi = {10.25934/pr00009018},
  url = {https://doi.org/10.25934/pr00009018}
}

RIS

TY  - JOUR
TI  - Differential effect of systemic antibiotics and proton pump inhibitors on clinical outcomes from immunotherapy or placebo as sequential therapy in patients with locally advanced, unresectable non-small cell lung cancer (stage III) who have not progressed following chemoradiation therapy: A post-hoc analysis of the PACIFIC trial.
AU  - Alessio Cortellini
PY  - 2024
DO  - 10.25934/pr00009018
UR  - https://doi.org/10.25934/pr00009018
ER  - 

APA

Cortellini, A. (2024). Differential effect of systemic antibiotics and proton pump inhibitors on clinical outcomes from immunotherapy or placebo as sequential therapy in patients with locally advanced, unresectable non-small cell lung cancer (stage III) who have not progressed following chemoradiation therapy: A post-hoc analysis of the PACIFIC trial.. https://doi.org/10.25934/pr00009018

Source records